TABLE 3.
Bacterial motility and chemotaxis in presence of catecholamines.
Bacterial species | Catecholamines (dose) | Antagonists | References |
Burkholderia pseudomallei Campylobacter jejuni NCTC11168 Escherichia coli O157:H7 Escherichia coli K12-MC1000 Pseudomonas aeruginosa PAO1 (H103) Pseudomonas aeruginosa PA14 Pseudomonas fluorescens MFN1032 |
Epi (50 μM) NE (100 μM) Epi, NE (100 μM) Epi, NE (50 μM) Epi, NE (50 μM) Epi (1–10 μM) NE (50–500 μM) Epi, NE, Dopamine Epi (10 μM) |
Phentolamine n. n. n. n. n. |
Intarak et al., 2014 Cogan et al., 2007 Xu et al., 2015 Bansal et al., 2007 Yang K. et al., 2014 Cambronel et al., 2019 Hegde et al., 2009 Freestone et al., 2012 Biaggini et al., 2015 |
Salmonella enterica serovar Typhimurium Vibrio anguillarum Vibrio campbellii |
NE (50 μM) NE (100 μM) Dopamine (100 μM) |
Phentolamine Phentolamine Phenoxybenzamine Propanolol Chlorpromazine |
Bearson and Bearson, 2008 Peterson et al., 2011 Pande et al., 2014 |
Vibrio harveyi (campbellii) | NE (50 μM) | Phentolamine Phenoxybenzamine Labetalol Propanolol LED209 |
Yang Q. et al., 2014 |
Dopamine (50 μM) | Chlorpromazine LED209 |
||
Vibrio parahaemolyticus | Epi (100 μM NE (50 μM) Dopamine (50 μM) |
LED209 | Yang et al., 2021 |
Yersinia ruckeri | NE (100 μM) Dopamine (100 μM) |
Propanolol Labetalol Phenoxybenzamine Chlorpromazine | Torabi Delshad et al., 2019 |
n, not used in the study.